Results 211 to 220 of about 356,945 (257)

Surgery for refractory epilepsy

Medical Journal of Australia, 1990
Over a six-year period, 130 patients with medically intractable epilepsy were assessed for possible surgical treatment. Initial assessment comprised full neurological and neuropsychological examination, computed tomographic and magnetic resonance imaging brain scanning, and simultaneous video and surface plus sphenoidal electroencephalographic (EEG ...
R A, Mackenzie, J M, Matheson, J S, Smith, M, Dwyer   +3 more
openaire   +2 more sources

How refractory is refractory epilepsy? Patterns of relapse and remission in people with refractory epilepsy

Epilepsy Research, 2011
Outcome studies in people with epilepsy have largely focused on the prognosis in the early stages and factors predictive of early remission. Few studies have examined prognosis in chronic refractory epilepsy.We determined the pattern of remission and relapse of epilepsy in a cohort of people with refractory epilepsy (seizures in the past two years, at ...
Aidan, Neligan, Gail S, Bell, Josemir W, Sander, Simon D, Shorvon   +3 more
openaire   +2 more sources

Proposed Consensus Definitions for New-Onset Refractory Status Epilepticus (NORSE), Febrile Infection-Related Epilepsy Syndrome (FIRES), and Related Conditions

Epilepsia, 2018
We convened an international group of experts to standardize definitions of New-Onset Refractory Status Epilepticus (NORSE), Febrile Infection-Related Epilepsy Syndrome (FIRES), and related conditions.
Nicholas S Abend, Sara Hocker, Teneille E Gofton   +2 more
exaly   +2 more sources

Management of Refractory Epilepsy

Topics in Companion Animal Medicine, 2013
The term refractory epilepsy is utilized in veterinary medicine to describe a condition in which an animal with epilepsy fails to attain satisfactory seizure control or suffers intolerable side effects despite appropriate therapy with conventional antiepileptic drugs.
openaire   +2 more sources

Electrostimulation for Refractory Epilepsy: A Review

Journal of Long-Term Effects of Medical Implants, 2016
Epilepsy is a neurological disorder that has been diagnosed in approximately 1% of the world's population. In North America alone, more than 3 million individuals suffer from epilepsy. Antiepileptic drugs are not fully effective in some patients, and most drugs have adverse side effects.
Chandrika, Shenoy, Hani, Aodah Alzahrani, Adrian R M, Upton, Markad V, Kamath   +3 more
openaire   +2 more sources

Stiripentol for focal refractory epilepsy

Cochrane Database of Systematic Reviews, 2015
This is an updated version of the original Cochrane review published in 2014 (Issue 1). For nearly 30% of people with epilepsy, seizures are not controlled by current treatments. Stiripentol is a new antiepileptic drug (AED) that was developed in France and was approved by the European Medicines Agency (EMA) in 2007 for the treatment of Dravet syndrome
BRIGO, Francesco, STORTI, Monica, Igwe, Stanley C.   +2 more
openaire   +3 more sources

Levetiracetam in Refractory Pediatric Epilepsy

Journal of Child Neurology, 2002
Levetiracetam, one of the newer-generation antiepilepsy drugs, is not currently approved for use in children. Given its favorable efficacy, pharmacokinetic, and, particularly, safety profile in adults, we felt that it may be a useful antiepilepsy drug for children with refractory epilepsy.
James W, Wheless, Yu-tze, Ng
openaire   +2 more sources

Early Identification of Refractory Epilepsy

New England Journal of Medicine, 2000
More than 30 percent of patients with epilepsy have inadequate control of seizures with drug therapy, but why this happens and whether it can be predicted are unknown. We studied the response to antiepileptic drugs in patients with newly diagnosed epilepsy to identify factors associated with subsequent poor control of seizures.We prospectively studied ...
P, Kwan, M J, Brodie
openaire   +2 more sources

Stiripentol for focal refractory epilepsy

2012
Nearly 30%of people with epilepsy do not have their seizures controlled with current treatments. Stiripentol is a new antiepileptic drug(AED) developed in France and recently approved by the European Medicines Agency (EMA) for the treatment of Dravet syndrome as an adjunctive therapy with valproate and clobazam, with a promising effect.To evaluate the ...
Francesco, Brigo, Monica, Storti
openaire   +2 more sources

Clobazam in refractory childhood epilepsy

The Indian Journal of Pediatrics, 2010
To evaluate the efficacy of clobazam in childhood refractory epilepsy and to characterize the adverse drug reaction profile in the Indian population.A cohort of 88 children with 'refractory' epilepsy was started on clobazam as add-on therapy. Diagnosis was established and seizure type recorded.
Veena, Kalra, Rachna, Seth, Devendra, Mishra, Narayan C, Saha   +3 more
openaire   +2 more sources